Literature DB >> 10352200

Effect of dialysate temperature on energy balance during hemodialysis: quantification of extracorporeal energy transfer.

F M van der Sande1, J P Kooman, J H Burema, P Hameleers, A M Kerkhofs, J M Barendregt, K M Leunissen.   

Abstract

An impaired vascular response is implicated in the pathogenesis of dialysis-induced hypotension, which is at least partly related to changes in extracorporeal blood temperature (Temp). However, little is known about changes in core Temp and differences in energy balance between standard and cool dialysis. In this study, core Temp and energy transfer between extracorporeal circuit and patient, as well as the blood pressure response, were assessed during dialysis with standard (37.5 degrees C) and cool (35.5 degrees C) Temp of the dialysate. Nine patients (4 men, 5 women; mean age, 69 +/-10 [SD] years) were studied during low- and standard-Temp dialysis, each serving as his or her own control. Bicarbonate dialysis and hemophane membranes were used. Energy transfer was assessed by continuous measurement of Temp in the arterial (Tart) and venous side (Tven) of the extracorporeal system according to the formula: c. rho.Qb*(Tven - Tart)*t, where c = specific thermal capacity (3.64 kJ/kg* degrees C), Qb = extracorporeal blood flow, rho = density of blood (1,052 kg/m3), and t = dialysis time (hours). Core Temp was also measured by Blood Temperature Monitoring (BTM; Fresenius, Bad Homburg, Germany). Core Temp increased during standard-Temp dialysis (36.7 degrees C +/- 0.3 degrees C to 37.2 degrees C +/- 0.2 degrees C; P < 0.05) despite a small negative energy balance (-85 +/- 43 kJ) from the patient to the extracorporeal circuit. During cool dialysis, energy loss was much more pronounced (-286 +/- 73 kJ; P < 0.05). However, mean core Temp remained stable (36.4 degrees C +/- 0.6 degrees C to 36.4 degrees C +/- 0.3 degrees C; P = not significant), and even increased in some patients with a low predialytic core Temp. Both during standard and cool dialysis, the increase in core Temp during dialysis was significantly related to predialytic core Temp (r = 0.88 and r = 0.77; P < 0.05). Systolic blood pressure (RR) decreased to a greater degree during standard-Temp dialysis compared with cool dialysis (43 +/- 21 v 22 +/- 26 mm Hg; P < 0.05), whereas diastolic RR tended to decrease more (15 +/- 10 v 0 +/- 19 mm Hg; P = 0.07). Core Temp increased in all patients during standard-Temp dialysis despite a small net energy transfer from the patient to the extracorporeal system. Concluding, Core Temp remained generally stable during cool dialysis despite significant energy loss from the patient to the extracorporeal circuit, and even increased in some patients with a low predialytic core Temp. The change in core Temp during standard and cool dialysis was significantly related to the predialytic blood Temp of the patient, both during cool- and standard-Temp dialysis. The results suggest that the hemodialysis procedure itself affects core Temp regulation, which may have important consequences for the vascular response during hypovolemia. The removal of heat by the extracorporeal circuit and/or the activation of autoregulatory mechanisms attempting to preserve core Temp might be responsible for the beneficial hemodynamic effects of cool dialysis.

Entities:  

Mesh:

Year:  1999        PMID: 10352200     DOI: 10.1016/S0272-6386(99)70149-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

Review 1.  Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis.

Authors:  Reem A Mustafa; Fadi Bdair; Elie A Akl; Amit X Garg; Heather Thiessen-Philbrook; Hassan Salameh; Sood Kisra; Gihad Nesrallah; Ahmad Al-Jaishi; Parth Patel; Payal Patel; Ahmad A Mustafa; Holger J Schünemann
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

2.  Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial.

Authors:  Ahmed A Al-Jaishi; Christopher W McIntyre; Jessica M Sontrop; Stephanie N Dixon; Sierra Anderson; Amit Bagga; Derek Benjamin; David Berry; Peter G Blake; Laura Chambers; Patricia C K Chan; Nicole Delbrouck; P J Devereaux; Luis F Ferreira-Divino; Richard Goluch; Laura Gregor; Jeremy M Grimshaw; Garth Hanson; Eduard Iliescu; Arsh K Jain; Charmaine E Lok; Reem A Mustafa; Bharat Nathoo; Gihad E Nesrallah; Matthew J Oliver; Sanjay Pandeya; Malvinder S Parmar; David Perkins; Justin Presseau; Eli Rabin; Joanna Sasal; Tanya Shulman; Manish M Sood; Andrew Steele; Paul Tam; Daniel Tascona; Davinder Wadehra; Ron Wald; Michael Walsh; Paul Watson; Walter Wodchis; Phillip Zager; Merrick Zwarenstein; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-02-05

3.  Control of core temperature and blood pressure stability during hemodialysis.

Authors:  Frank M van der Sande; Grzegorz Wystrychowski; Jeroen P Kooman; Laura Rosales; Jochen Raimann; Peter Kotanko; Mary Carter; Christopher T Chan; Karel M L Leunissen; Nathan W Levin
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-08       Impact factor: 8.237

4.  Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis.

Authors:  Yasushi Tsujimoto; Hiraku Tsujimoto; Yukihiko Nakata; Yuki Kataoka; Miho Kimachi; Sayaka Shimizu; Tatsuyoshi Ikenoue; Shingo Fukuma; Yosuke Yamamoto; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

5.  Prevalence and risk factors of intra-dialytic hypotension: a 5 year retrospective report from a single Nigerian Centre.

Authors:  Ogochukwu Chinedum Okoye; Henry Enyinmisan Slater; Nilum Rajora
Journal:  Pan Afr Med J       Date:  2017-09-21

6.  Pro-inflammatory cytokines as potential predictors for intradialytic hypotension.

Authors:  Jinbo Yu; Xiaohong Chen; Yang Li; Yaqiong Wang; Xuesen Cao; Zhonghua Liu; Bo Shen; Jianzhou Zou; Xiaoqiang Ding
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.